Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · IEX Real-Time Price · USD

21.87

-1.42 (-6.10%)

At close: Apr 25, 2024, 4:00 PM

22.27

+0.40 (1.83%)

After-hours: Apr 25, 2024, 7:05 PM EDT

Arrowhead Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2003
Cash & Equivalents	110.89	108.01	184.43	143.58	221.8	30.13	24.84	85.37	81.21	132.51	Upgrade
Short-Term Investments	292.74	268.39	183.36	171.91	36.9	46.4	40.77	0	17.54	21.65	Upgrade
Cash & Cash Equivalents	403.63	376.4	367.79	315.49	258.7	76.53	65.61	85.37	98.75	154.16	Upgrade
Cash Growth	7.23%	2.34%	16.58%	21.95%	238.03%	16.65%	-23.15%	-13.56%	-35.94%	447.75%	Upgrade
Receivables	0	1.41	10.26	0.85	0.66	0.33	0.07	0.08	0	0	Upgrade
Other Current Assets	15.9	27.49	6.55	6.03	5.88	1.91	2.23	5.06	4.12	0.64	Upgrade
Total Current Assets	419.52	405.3	384.6	322.37	265.25	78.77	67.9	90.5	102.87	154.8	Upgrade
Property, Plant & Equipment	335.56	168.59	66.02	47.02	23.21	13.94	15.51	15.39	4.53	3.87	Upgrade
Long-Term Investments	0	105.87	245.6	137.49	44.18	0	0	0	0	23.09	Upgrade
Goodwill and Intangibles	10.26	11.96	13.66	15.36	17.06	18.76	20.46	22.16	24.82	1.01	Upgrade
Other Long-Term Assets	0.21	0.22	0.27	0.26	0.14	0.14	0.14	0.12	0.05	0.04	Upgrade
Total Long-Term Assets	346.03	286.64	325.55	200.13	84.6	32.84	36.12	37.67	29.4	28.02	Upgrade
Total Assets	765.55	691.94	710.15	522.5	349.85	111.61	104.02	128.18	132.27	182.82	Upgrade
Accounts Payable	35.87	2.87	9.46	6.83	7.65	2.81	4.08	12.23	5.03	2.58	Upgrade
Deferred Revenue	0.87	130.05	242.55	19.29	82.8	0	5.27	5.07	0.1	0.1	Upgrade
Current Debt	10.56	2.78	2.25	1.1	0	0.22	0.21	0.19	0.22	0.26	Upgrade
Other Current Liabilities	58.16	3.16	-107.72	13.47	6.62	9.33	9.15	8.15	10.55	8.9	Upgrade
Total Current Liabilities	105.46	138.85	146.54	40.68	97.07	12.36	18.7	25.64	15.9	11.85	Upgrade
Long-Term Debt	104.61	78.8	23.3	20.04	0	2.1	2.33	2.53	0.54	0.76	Upgrade
Other Long-Term Liabilities	268.33	55.95	131.5	0	8.74	1.9	2.13	4.97	6.2	4.23	Upgrade
Total Long-Term Liabilities	372.93	134.75	154.79	20.04	8.74	4	4.45	7.51	6.75	4.98	Upgrade
Total Liabilities	478.39	273.6	301.33	60.73	105.81	16.37	23.16	33.15	22.65	16.83	Upgrade
Total Debt	115.17	81.58	25.55	21.14	0	2.33	2.53	2.73	0.76	1.02	Upgrade
Debt Growth	41.18%	219.34%	20.85%	-	-	-8.23%	-7.12%	259.70%	-25.82%	-55.63%	Upgrade
Retained Earnings	-1,026.03	-820.76	-644.69	-503.84	-419.29	-487.27	-432.82	-398.44	-316.71	-224.77	Upgrade
Comprehensive Income	-3.22	-0.14	-0.07	0.02	-0.39	-0.02	0.03	0.01	-0.14	0	Upgrade
Shareholders' Equity	271.34	398.52	408.82	461.78	244.59	95.8	81.42	95.58	110.18	166.54	Upgrade
Net Cash / Debt	288.46	294.82	342.24	294.36	258.7	74.21	63.07	82.64	98	153.14	Upgrade
Net Cash / Debt Growth	-2.16%	-13.86%	16.27%	13.78%	248.62%	17.65%	-23.67%	-15.67%	-36.01%	492.64%	Upgrade
Net Cash Per Share	2.70	2.80	3.30	2.92	2.62	0.89	0.85	1.35	1.71	3.26	Upgrade
Working Capital	314.07	266.45	238.06	281.69	168.18	66.4	49.2	64.86	86.97	142.95	Upgrade
Book Value Per Share	2.54	3.78	3.94	4.58	2.61	1.15	1.10	1.57	1.92	3.55	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).